<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p76" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_76{left:130px;bottom:1196px;letter-spacing:-0.15px;}
#t2_76{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_76{left:293px;bottom:1114px;}
#t4_76{left:321px;bottom:1115px;letter-spacing:-0.01px;}
#t5_76{left:293px;bottom:1094px;}
#t6_76{left:321px;bottom:1095px;letter-spacing:-0.01px;}
#t7_76{left:238px;bottom:1066px;letter-spacing:-0.01px;}
#t8_76{left:238px;bottom:1047px;letter-spacing:-0.01px;}
#t9_76{left:238px;bottom:1027px;letter-spacing:-0.01px;}
#ta_76{left:238px;bottom:1008px;letter-spacing:-0.01px;}
#tb_76{left:128px;bottom:959px;letter-spacing:-0.18px;}
#tc_76{left:238px;bottom:959px;letter-spacing:-0.19px;}
#td_76{left:238px;bottom:930px;letter-spacing:-0.01px;}
#te_76{left:238px;bottom:911px;letter-spacing:-0.01px;}
#tf_76{left:238px;bottom:892px;letter-spacing:-0.01px;}
#tg_76{left:238px;bottom:872px;letter-spacing:-0.01px;}
#th_76{left:238px;bottom:818px;letter-spacing:-0.01px;}
#ti_76{left:238px;bottom:799px;letter-spacing:-0.01px;}
#tj_76{left:238px;bottom:779px;letter-spacing:-0.01px;}
#tk_76{left:238px;bottom:760px;letter-spacing:-0.01px;}
#tl_76{left:238px;bottom:740px;letter-spacing:-0.01px;}
#tm_76{left:238px;bottom:721px;letter-spacing:-0.01px;}
#tn_76{left:238px;bottom:701px;letter-spacing:-0.01px;}
#to_76{left:238px;bottom:682px;letter-spacing:-0.01px;}
#tp_76{left:238px;bottom:628px;letter-spacing:-0.01px;}
#tq_76{left:238px;bottom:608px;letter-spacing:-0.01px;}
#tr_76{left:238px;bottom:589px;letter-spacing:-0.01px;}
#ts_76{left:238px;bottom:569px;letter-spacing:-0.01px;}
#tt_76{left:238px;bottom:550px;letter-spacing:-0.01px;}
#tu_76{left:238px;bottom:531px;letter-spacing:-0.01px;}
#tv_76{left:238px;bottom:511px;letter-spacing:-0.01px;}
#tw_76{left:238px;bottom:492px;letter-spacing:-0.01px;}
#tx_76{left:238px;bottom:472px;letter-spacing:-0.01px;}
#ty_76{left:238px;bottom:453px;letter-spacing:-0.01px;}
#tz_76{left:238px;bottom:379px;letter-spacing:-0.01px;}
#t10_76{left:238px;bottom:360px;letter-spacing:-0.01px;}
#t11_76{left:238px;bottom:340px;letter-spacing:-0.01px;}
#t12_76{left:238px;bottom:321px;letter-spacing:-0.01px;}
#t13_76{left:238px;bottom:302px;letter-spacing:-0.01px;}
#t14_76{left:238px;bottom:282px;letter-spacing:-0.01px;}
#t15_76{left:238px;bottom:263px;letter-spacing:-0.01px;}
#t16_76{left:238px;bottom:243px;letter-spacing:-0.01px;}
#t17_76{left:238px;bottom:170px;letter-spacing:-0.01px;}
#t18_76{left:238px;bottom:150px;letter-spacing:-0.01px;}
#t19_76{left:238px;bottom:131px;letter-spacing:-0.01px;}
#t1a_76{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_76{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_76{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_76{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_76{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_76{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts76" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg76Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg76" style="-webkit-user-select: none;"><object width="908" height="1286" data="76/76.svg" type="image/svg+xml" id="pdf76" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_76" class="t s0_76">7.3. Fundamental considerations of multimodal therapy approaches </span><span id="t2_76" class="t s1_76">76 </span>
<span id="t3_76" class="t s2_76">• </span><span id="t4_76" class="t s3_76">regular follow-up not possible </span>
<span id="t5_76" class="t s2_76">• </span><span id="t6_76" class="t s3_76">Pregnancy or breastfeeding </span>
<span id="t7_76" class="t s3_76">In principle, organ preservation protocols should currently only be used in exceptional cases </span>
<span id="t8_76" class="t s3_76">outside of studies due to the many unanswered questions. The early good response to </span>
<span id="t9_76" class="t s3_76">induction chemotherapy has proven to be advantageous for the successful selection of suitable </span>
<span id="ta_76" class="t s3_76">patients [198, 252]. </span>
<span id="tb_76" class="t s4_76">7.3.3. </span><span id="tc_76" class="t s4_76">Late toxicity </span>
<span id="td_76" class="t s3_76">Simultaneous chemoradiotherapy of locally advanced laryngeal carcinoma is often used as an </span>
<span id="te_76" class="t s3_76">alternative to laryngectomy with the aim of organ and function preservation. The treatment </span>
<span id="tf_76" class="t s3_76">results in terms of local tumor control and survival are good. However, both acute and late </span>
<span id="tg_76" class="t s3_76">toxicity are pronounced. </span>
<span id="th_76" class="t s3_76">The publication on the so-called "T-score relative risk scale" by Trotti [253] impressively shows </span>
<span id="ti_76" class="t s3_76">how acute toxicity has increased over the last decades due to dose and modality intensification. </span>
<span id="tj_76" class="t s3_76">The observed acute toxicity has increased fivefold from normal fractionated adjuvant radiation </span>
<span id="tk_76" class="t s3_76">to hyperfractionated radiochemotherapy [253]. The direct comparison of the side effects of </span>
<span id="tl_76" class="t s3_76">individual procedures is made difficult by the fact that there is no uniform classification and </span>
<span id="tm_76" class="t s3_76">documentation of side effects across all studies and that the incidence of late side effects </span>
<span id="tn_76" class="t s3_76">increases with the follow-up period. Often, not all cofactors are adequately documented and </span>
<span id="to_76" class="t s3_76">presented in studies. </span>
<span id="tp_76" class="t s3_76">Late toxicity manifests itself primarily in persistent, progressive dysphagia with aspiration, </span>
<span id="tq_76" class="t s3_76">which may occur more than 5 years after completion of therapy. Dysphagia may be caused by </span>
<span id="tr_76" class="t s3_76">the formation of strictures as a result of radiation-induced mucosal ulceration or by impaired </span>
<span id="ts_76" class="t s3_76">motility due to radiation-induced, progressive fibrosis of the pharyngeal muscles. In an analysis </span>
<span id="tt_76" class="t s3_76">of all RTOG studies with simultaneous radiochemotherapy of advanced head and neck tumors, </span>
<span id="tu_76" class="t s3_76">tumor location in the larynx/hypopharynx, tumor size, and neck dissection after definitive </span>
<span id="tv_76" class="t s3_76">radiotherapy were risk factors for severe long-term toxicity in decreasing order of importance </span>
<span id="tw_76" class="t s3_76">[254]. Swallowing disorders and laryngeal problems accounted for 75% of late effects and were </span>
<span id="tx_76" class="t s3_76">found in a good 30% of patients in the simultaneous radiochemotherapy arm of the US study </span>
<span id="ty_76" class="t s3_76">on larynx preservation (RTOG-9111) [187]. </span>
<span id="tz_76" class="t s3_76">Dysphagia can often result in silent aspiration and subsequent late pulmonary </span>
<span id="t10_76" class="t s3_76">complications. The prevalence is underestimated because silent aspiration can only be </span>
<span id="t11_76" class="t s3_76">diagnosed by radiological (contrast medium passage) or endoscopic (FEES) procedures [250]. </span>
<span id="t12_76" class="t s3_76">Dysphagia can occur after both simultaneous chemoradiotherapy and adjuvant </span>
<span id="t13_76" class="t s3_76">(chemo)radiotherapy and is essentially dependent on the radiation dose applied to the </span>
<span id="t14_76" class="t s3_76">constrictors [255]. Adequate swallowing rehabilitation in an interdisciplinary team can </span>
<span id="t15_76" class="t s3_76">improve swallowing function, reduce aspiration and improve the quality of life of affected </span>
<span id="t16_76" class="t s3_76">patients. </span>
<span id="t17_76" class="t s3_76">Fibrosis of the neck muscles, late edema in the entire larynx [216], neuropathies and </span>
<span id="t18_76" class="t s3_76">scarring of the mucosa contribute to a slowly increasing dysphagia over several months </span>
<span id="t19_76" class="t s3_76">with possible latent aspiration, which in some </span>
<span id="t1a_76" class="t s0_76">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
